MATINAS BIOPHARMA HLDGS INC's ticker is MTNB and the CUSIP is 576810105. A total of 53 filers reported holding MATINAS BIOPHARMA HLDGS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2024 | $440,104 | +25.3% | 1,624,000 | 0.0% | 0.03% | +13.3% |
| Q4 2023 | $351,109 | +93.1% | 1,624,000 | +16.1% | 0.03% | +76.5% |
| Q3 2023 | $181,870 | -63.9% | 1,399,000 | 0.0% | 0.02% | -71.2% |
| Q2 2023 | $503,640 | -23.4% | 1,399,000 | 0.0% | 0.06% | -24.4% |
| Q1 2023 | $657,530 | -6.0% | 1,399,000 | 0.0% | 0.08% | -16.1% |
| Q4 2022 | $699,500 | -21.4% | 1,399,000 | 0.0% | 0.09% | -31.1% |
| Q3 2022 | $890,000 | -19.5% | 1,399,000 | 0.0% | 0.14% | -17.7% |
| Q2 2022 | $1,105,000 | -1.8% | 1,399,000 | 0.0% | 0.16% | +11.6% |
| Q1 2022 | $1,125,000 | -20.4% | 1,399,000 | 0.0% | 0.15% | -21.4% |
| Q4 2021 | $1,413,000 | -22.3% | 1,399,000 | 0.0% | 0.19% | -28.6% |
| Q3 2021 | $1,818,000 | +570.8% | 1,399,000 | +299.7% | 0.26% | +693.9% |
| Q2 2021 | $271,000 | – | 350,000 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Boxer Capital, LLC | 10,188,312 | $8,727,000 | 0.75% |
| Vivo Capital, LLC | 6,818,181 | $5,840,000 | 0.55% |
| Stonepine Capital Management, LLC | 668,615 | $573,000 | 0.40% |
| Telemetry Investments, L.L.C. | 574,619 | $492,000 | 0.38% |
| Broadfin Capital, LLC | 766,708 | $657,000 | 0.14% |
| Granite Point Capital Management, L.P. | 1,500,000 | $1,285,000 | 0.09% |
| STALEY CAPITAL ADVISERS INC | 200,000 | $171,000 | 0.01% |
| HYMAN CHARLES D | 79,800 | $68,000 | 0.01% |
| CRA Financial Services, LLC | 10,000 | $9,000 | 0.01% |
| BRIGHTON JONES LLC | 50,000 | $43,000 | 0.01% |